Natixis Advisors LLC Purchases 1,395 Shares of Addus HomeCare Co. (NASDAQ:ADUS)

Natixis Advisors LLC increased its position in shares of Addus HomeCare Co. (NASDAQ:ADUSFree Report) by 3.6% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 39,956 shares of the company’s stock after buying an additional 1,395 shares during the period. Natixis Advisors LLC owned 0.22% of Addus HomeCare worth $5,008,000 at the end of the most recent reporting period.

A number of other large investors have also bought and sold shares of ADUS. Wasatch Advisors LP grew its holdings in Addus HomeCare by 11.8% in the third quarter. Wasatch Advisors LP now owns 1,043,240 shares of the company’s stock worth $138,782,000 after purchasing an additional 110,010 shares during the period. TimesSquare Capital Management LLC grew its holdings in Addus HomeCare by 28.5% in the fourth quarter. TimesSquare Capital Management LLC now owns 355,750 shares of the company’s stock worth $44,593,000 after purchasing an additional 78,835 shares during the period. Principal Financial Group Inc. grew its holdings in Addus HomeCare by 17.5% in the third quarter. Principal Financial Group Inc. now owns 505,853 shares of the company’s stock worth $67,293,000 after purchasing an additional 75,409 shares during the period. Raymond James Financial Inc. acquired a new stake in Addus HomeCare in the fourth quarter worth $6,637,000. Finally, King Luther Capital Management Corp acquired a new stake in Addus HomeCare in the fourth quarter worth $4,223,000. 95.35% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of equities research analysts have commented on ADUS shares. StockNews.com cut shares of Addus HomeCare from a “buy” rating to a “hold” rating in a report on Wednesday, February 26th. Citizens Jmp upgraded shares of Addus HomeCare to a “strong-buy” rating in a report on Monday, December 16th. Oppenheimer lifted their price objective on shares of Addus HomeCare from $145.00 to $150.00 and gave the company an “outperform” rating in a report on Friday, January 24th. Macquarie reiterated an “outperform” rating and set a $129.00 price objective on shares of Addus HomeCare in a report on Thursday, February 27th. Finally, Stephens reiterated an “overweight” rating and set a $142.00 price objective on shares of Addus HomeCare in a report on Wednesday, March 12th. One research analyst has rated the stock with a sell rating, one has given a hold rating, seven have given a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, Addus HomeCare has an average rating of “Moderate Buy” and a consensus target price of $132.78.

Get Our Latest Analysis on ADUS

Addus HomeCare Price Performance

ADUS opened at $89.83 on Friday. The company’s 50-day moving average is $111.83 and its 200 day moving average is $121.87. Addus HomeCare Co. has a fifty-two week low of $87.88 and a fifty-two week high of $136.72. The firm has a market capitalization of $1.63 billion, a P/E ratio of 20.56, a PEG ratio of 1.41 and a beta of 0.97.

Addus HomeCare (NASDAQ:ADUSGet Free Report) last released its quarterly earnings results on Monday, February 24th. The company reported $1.26 earnings per share for the quarter, missing analysts’ consensus estimates of $1.35 by ($0.09). Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. The firm had revenue of $297.14 million for the quarter, compared to the consensus estimate of $291.04 million. On average, equities research analysts expect that Addus HomeCare Co. will post 4.59 earnings per share for the current year.

Insider Activity at Addus HomeCare

In related news, CEO R Dirk Allison sold 25,000 shares of the firm’s stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $124.76, for a total transaction of $3,119,000.00. Following the transaction, the chief executive officer now directly owns 79,397 shares of the company’s stock, valued at $9,905,569.72. This trade represents a 23.95 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 4.60% of the stock is owned by insiders.

Addus HomeCare Profile

(Free Report)

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.

Recommended Stories

Institutional Ownership by Quarter for Addus HomeCare (NASDAQ:ADUS)

Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.